Karin Rosen
Chief Tech/Sci/R&D Officer bei HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Aktive Positionen von Karin Rosen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 02.11.2020 | - |
| DIAMYD MEDICAL AB | Director/Board Member | 10.03.2023 | - |
Karriereverlauf von Karin Rosen
Ehemalige bekannte Positionen von Karin Rosen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01.11.2018 | 01.11.2020 |
Ausbildung von Karin Rosen
| University of Lund | Doctorate Degree |
Statistik
International
| Schweden | 3 |
| Irland | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GSK PLC | Health Technology |
| DIAMYD MEDICAL AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Börse
- Insiders
- Karin Rosen
- Erfahrung
